[ 3 / biz / cgl / ck / diy / fa / ic / jp / lit / sci / vr / vt ] [ index / top / reports ] [ become a patron ] [ status ]
2023-11: Warosu is now out of extended maintenance.

/biz/ - Business & Finance

Search:


View post   

>> No.21300506 [View]
File: 80 KB, 1024x683, 1515642255293.jpg [View same] [iqdb] [saucenao] [google]
21300506

>>21299990
>the death knell of boomer finance

>> No.17234579 [View]
File: 80 KB, 1024x683, 1515642255293.jpg [View same] [iqdb] [saucenao] [google]
17234579

>>17234500
IV Rigosertib will very likely be approved. It's just a matter of when it actually happens. The drug is like 15 years in the making. Then they have the combination trial for oral Rigosertib with BMY's namebrand azacitidine (which was acquired when they purchased Celgene). That's still in Phase 2. But that's why there is also rumors of BMY buying ONTX. And I think they would probably get bought out for higher than $2. Rigosertib on its own has potential for billions in sales. But it's all just speculation. And it just had a shitcoin tier pump and dump. That's why it's 0.53.

Navigation
View posts[+24][+48][+96]